Discovery of AMG 232, a potent, selective, and orally bioavailable MDM2-p53 inhibitor in clinical development (Q27643965)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Discovery of AMG 232, a potent, selective, and orally bioavailable MDM2-p53 inhibitor in clinical development |
scientific article |
Statements
Discovery of AMG 232, a potent, selective, and orally bioavailable MDM2-p53 inhibitor in clinical development (English)
Daqing Sun
Xuelei Yan
Zhihong Li
Yosup Rew
Michael Gribble
Michael D Bartberger
Hilary P Beck
Jude Canon
Ada Chen
Xiaoqi Chen
David Chow
Jeffrey Deignan
Jason Duquette
John Eksterowicz
Benjamin Fisher
Brian M Fox
Jiasheng Fu
Ana Z Gonzalez
Felix Gonzalez-Lopez De Turiso
Jonathan B Houze
Xin Huang
Min Jiang
Lixia Jin
Frank Kayser
Jiwen Jim Liu
Mei-Chu Lo
Alexander M Long
Brian Lucas
Lawrence R McGee
Joel McIntosh
Jeff Mihalic
Jonathan D Oliner
Tao Osgood
Matthew L Peterson
Philip Roveto
Paul Shaffer
Maria Toteva
Yingcai Wang
Yu Chung Wang
Sarah Wortman
Peter Yakowec
Ming Yu
Xiaoning Zhao
Jing Zhou
Jiang Zhu
Steven H Olson
Julio C Medina
Identifiers
2 references
2 references